CORONAVIRUS INFECTION AND ITS CONTROL THROUGH VARIOUS APPROACHES: A SHORT REVIEW
DOI:
https://doi.org/10.29121/granthaalayah.v9.i3.2021.3769Keywords:
Homeopathy, Allopathy, Vaccination For Treating COVID-19 PandemicAbstract [English]
Coronavirus is a common virus causing very serious issues to public health. This virus, SARS-COV-2, has disseminated worldwide respiratory illness, designated as COVID-19. This viral infection disturbs people in various ways. A lot of people infested due to this virus develop a mild illness and get relief soon without any sort of hospitalization. But mostly, it becomes highly severe later and the patient has to undergo shortening of breath as well as some other chest-related abnormalities like Middle East Respiratory Syndrome (MERS) and Acute Respiratory Syndrome. In this manuscript, we have discussed multiple areas like symptomatology, management approaches including Homoeopathic and Allopathic (drugs) treatments, plus vaccination. Lastly, we have put in the conclusion of overall literature, and most importantly implicated or suggested certain new research areas for the researchers to explore which may assist in preventing further spread of this threatening syndrome now and in the future.
Downloads
References
Boericke, W. 2020. Homoeopathic Materia Medica. Retrieved 27 April 2020, from http://www.homeoint.org/books/boericmm/ 15. James Tyler Kent. Lectures on Homoeopathic material Medica; Retrieved 28 April, 2020 from https://homeopathybulgaria.org/todormed/JAMES%20TYLER%20KENTLectures%20ON%20HOMEOPATHIC%20MATERIA %20MEDICA.pdf
Burt, William H. Physiological materia medica, containing all that is known of the physiological action of our remedies; together with their characteristic indications and pharmacology. (Chicago, Gross & Delbridge, 1881.
Deng, L., Li, C., Zeng, Q., Liu, X., Li, X., Zhang, H., Hong, Z., Xia, J. (2020). Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. J. Infect. 81, e1– e5, https://doi.org/10.1016/j.jinf.2020.03.002 DOI: https://doi.org/10.1016/j.jinf.2020.03.002
Gordon, C.J., Tchesnokov, Feng, J.Y. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. Journal of Biological Chemistry. 295: 4773-4779. https://doi.org/10.1074/jbc.AC120.013056. DOI: https://doi.org/10.1074/jbc.AC120.013056
Hung, I. F., Lung, K. C., Tso, E. Y et al. (2020). Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet, 395, 1695– 1704, https://doi.org/10.1016/S0140-6736(20)31042-4 DOI: https://doi.org/10.1016/S0140-6736(20)31042-4
Kong, R., Yang, G et al. (2020). COVID-19 docking server: an interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19. arXiv preprint arXiv:2003.00163.https://doi.org/10.1093/bioinformatics/btaa645. DOI: https://doi.org/10.1093/bioinformatics/btaa645
Kosyna, F.K., Nagel, M., Kluxen, L. et al. (2015). The importin α/β-specific inhibitor ivermectin affects HIF-dependent hypoxia response pathways. Biological Chemistry. 396: 1357-1367. https://doi.org/10.1515/hsz-2015-0171. DOI: https://doi.org/10.1515/hsz-2015-0171
Lai, C.C., Shih, T.P., Ko, W.C., Tang, H.J. and Hsueh, P.R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents. 105924. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105924
Nania,R., Christina, I. and Dena, B. (2021). What to Know About the Coronavirus Vaccines. AARP. https://www.aarp.org/health/conditions-treatments/info-2020/coronavirus-vaccine-research.html
Nicola, M., O’Neill, N., Sohrabi, C., Khan, M., Agha, M. and Agha, R. (2020). Evidence based management guideline for the COVID-19 pandemic-review article. International Journal of Surgery. 77: 206-216.
Parikh, N. and Parikh, D. (2020). Role of homoeopathy in COVID-19 Management-A clinical experience. World Journal of Pharmaceutical Research. 9(5): 2459-2466.
Ramesh, N., Siddaiah, A. and Joseph, B. (2020). Tackling corona virus disease 2019 (COVID 19) in workplaces. Indian Journal of Occupational and Environmental Medicine. 24(1): 16-18.
Sajed, A.N. and Amgain, K. (2020). Corona virus disease (COVID-19) outbreak and the strategy for prevention. Europasian Journal of Medical Sciences. 2(1): 1-3.
Shittu M.O., Afolami O.I. (2020). Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc additives- a better synergy for future COVID-19 clinical trials. Infez Med. 28: 192-197.
Talwar, S., Sood, S., Kumar, J., Chauhan, R., Sharma, M. and Tuli, H.S. (2020). Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020. Current pharmacology reports, pp.1-10.s
Wagstaff K.M, Sivakumaran H, Heaton S.M et al. (2012). Ivermectin is a specific inhibitor of importin α/β- mediated nuclear importable to inhibit replication of HIV-1 and dengue virus. Biochemistry Journal. 443: 851-856. https://doi.org/10.1042/BJ20120150. DOI: https://doi.org/10.1042/BJ20120150
Wang M., Cao, R., Zhang, L et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research. 30: 269-271. https://doi.org/10.1038/s41422-020-0282-0. DOI: https://doi.org/10.1038/s41422-020-0282-0
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.